Make Your Year-End Gift TODAY and Your Gift Will be Matched
Join our donors in supporting OCRA and your gift will have double the impact in the fight against ovarian cancer. Thanks to a generous year-end pledge from angel patrons and … Continued
News
OCRA Funded Research Delves Deeper into How PARPi Work
(December 21, 2018) This month, researchers in Boston published their findings on how PARP inhibitors (PARPi) cause a chain reaction of responses from the tumor and its environment. Study authors, … Continued
FDA Approves Olaparib for Frontline Maintenance Treatment in Ovarian Cancer
(December 20, 2018) Earlier this year a phase III clinical trial, known as SOLO-1, showed that frontline olaparib (Lynparza) can reduce the risk of disease progression or death by up … Continued
Neoadjuvant Chemotherapy Recommended for Stage IV Tubo-Ovarian Cancer
(December 7, 2018) A study published last month analyzed two clinical trials that sought to determine the best first step for advanced tubo-ovarian cancers, neoadjuvant chemotherapy or debulking surgery. The … Continued
OCRA Holiday Card Raises Funds for a Cure
OCRA Holiday Card Raises Funds for a Cure
Holiday Greeting Cards that Give Back Send your friends and family customizable cards from Picaboo Cards for Causes and show your support for finding an ovarian cancer cure. The front … Continued
On #GivingTuesday, Join us in #GivingTeal to End Ovarian Cancer
#GivingTuesday is November 27th, and we need you to help us make a big impact! Please join us in #GivingTeal, for the 22,000 American women diagnosed with ovarian cancer every … Continued
Simple Cysts Found by Ultrasound Don’t Require Action
(November 16, 2018) JAMA Internal Medicine recently published an eleven year study of over 72,000 women that found having a simple ovarian cyst does not increase one’s risk of ovarian … Continued
For Some, Statin Use Can Decrease the Risk of Ovarian Cancer
(November 13, 2018) The International Journal of Cancer recently published a study that explored the use of statins, which reduces one’s lipids, and their effect on ovarian cancer risk. After … Continued
World Ovarian Cancer Coalition Releases Every Woman Study Report
(October 25, 2018) Through a series of surveys, interviews, and literature reviews the World Ovarian Cancer Coalition produced a report that detailed their findings and recommendations. Their study spanned the … Continued
Maintenance olaparib Improves Progression-Free Survival in Phase III Clinical Trial
(October 23, 2018) Olaparib, or Lynparza, was shown to increase progression-free survival (PFS) by almost three years in an ongoing trial known as SOLO-1. The women in the study are … Continued
OCRA Research Shows How Cancer Cells Negatively Impact the Communication between the Ovary and Fallopian Tube
(October 22, 2018) A team at the University of Illinois at Chicago, including OCRA grantee Matthew Dean, PhD, recently discovered the role that cancer cells have on their immediate environment. … Continued
Study Looks at Long-term Survival Trends in Ovarian Cancer
(October 19, 2018) A retroactive study using SEER, or Surveillance, Epidemiology, and End Results, looked at the trends in ovarian cancer from 1983 to 2012. In almost 3 decades, the … Continued